Victoza® Prefilled Pen for Type 2 Diabetes

Victoza is a GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes. This overview explains how the pen works, who it suits, and how to handle dosing and storage. It also outlines access options through our platform.

What Victoza Is and How It Works

Victoza® contains liraglutide, a GLP-1 receptor agonist that helps lower blood glucose by enhancing glucose-dependent insulin release, reducing glucagon, and slowing gastric emptying. It is available for US delivery from Canada, and cash-pay options include the Victoza pen without insurance. This medicine is not insulin and is not for type 1 diabetes or diabetic ketoacidosis.

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

Mechanistically, the treatment acts when glucose is present, which can reduce hypoglycemia risk versus some therapies used alone. It can also support weight reduction for some people; however, its primary indication is glycemic control and cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease, as reflected in approved labeling.

Who It’s For

This medicine is indicated for adults with type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It may be used alone or with other agents such as metformin. It is not approved for weight loss; a higher-dose liraglutide product is labeled for chronic weight management.

Do not use if there is a personal or family history of medullary thyroid carcinoma or if diagnosed with multiple endocrine neoplasia syndrome type 2. Avoid if there is a known serious hypersensitivity to liraglutide or any component of the formulation. Use caution in those with a history of pancreatitis, severe gastrointestinal disease, or gallbladder disease. Discuss use during pregnancy or breastfeeding with a healthcare professional.

Dosage and Usage

Standard initiation follows the approved schedule. Start at 0.6 mg once daily for one week. Increase to 1.2 mg once daily. If additional glycemic control is needed, the dose may be increased to 1.8 mg once daily. The therapy is administered subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites with each dose.

Use the pen at the same time each day, with or without food. Do not share pens or needles. Prime the pen before first use following the manufacturer’s instructions. If used with insulin or a sulfonylurea, monitor for hypoglycemia. The Victoza 18 mg/3 mL prefilled pen is a multidose device that allows selection of the prescribed daily dose on the dial.

For technique details, see the dosing guide article Dosing Guide and the overview on injection sites Injection Sites. General pen skills are reviewed in Use Insulin Pen.

Strengths and Forms

The class is supplied as a clear, colorless solution in a prefilled, multi-dose pen. Availability may vary by pharmacy.

• Presentation: Liraglutide injection pen 6 mg/mL solution in a 3 mL prefilled device
• Dose selection: Daily dose is dialed on the pen as directed
• Supplies: Pen needles are required and procured separately

Carton sizes can differ by market and stock. Always review the carton and pen label before first use.

Missed Dose and Timing

If a dose is missed, administer as soon as remembered within 12 hours of the scheduled time. If more than 12 hours have passed, skip the missed dose and take the next dose at the usual time the following day. Do not take extra doses or increase the dialed amount to make up for a missed dose. After several missed days, re-titration from the starting dose may be considered per the official label; discuss the approach with a prescriber.

Storage and Travel Basics

Unopened pens should be refrigerated until first use. Do not freeze. Protect from light by keeping the cap on when not in use. After first use, pens may be stored at room temperature or refrigerated; discard the pen 30 days after first use. Keep out of reach of children.

During travel, pack the pen with a cool source if needed to avoid extreme heat. Do not store the pen in a car glovebox. Keep the pen in a carry-on bag when flying. Bring a copy of the prescription and supplies for the entire trip. Dispose of used needles in a proper sharps container.

Pen Handling and Sharps Disposal

• Check solution: use only if clear and colorless, without particles
• Attach a new needle for each injection
• Prime per the manufacturer’s first-use instructions
• Dial the prescribed dose and inject into recommended areas
• Count slowly before removing the needle to ensure full dose
• Never share pens or needles with anyone
• Dispose of needles in an approved sharps container

Benefits

This therapy can reduce A1C when used as directed. It may lower postprandial and fasting glucose by its glucose-dependent mechanism. Some people may experience modest weight reduction, which can support metabolic goals. A once-daily schedule and the prefilled device may simplify routine for many treatment plans. Cardiovascular risk reduction is supported for adults with type 2 diabetes and established cardiovascular disease based on labeling.

Side Effects and Safety

• Nausea or vomiting
• Diarrhea or constipation
• Abdominal pain or bloating
• Decreased appetite or dyspepsia
• Headache or fatigue
• Injection-site redness or itching

Serious risks include pancreatitis, gallbladder disease, kidney problems from dehydration, severe allergic reactions, and a potential risk of thyroid C-cell tumors. Stop treatment and seek medical care for severe, persistent abdominal pain, especially if radiating to the back, or for symptoms of anaphylaxis. When combined with insulin or sulfonylureas, hypoglycemia can occur; monitor accordingly.

Drug Interactions and Cautions

Concomitant use with insulin or sulfonylureas can increase hypoglycemia risk. Because gastric emptying is delayed, absorption of some oral medicines may be affected; monitor narrow-therapeutic-index drugs per clinical guidance. Do not use with other liraglutide-containing products. Use caution in renal impairment, dehydration, or history of pancreatitis. Report any signs of gallbladder disease. Alcohol can worsen gastrointestinal effects and glycemic variability.

What to Expect Over Time

Gastrointestinal symptoms often occur at initiation and after dose increases. These effects typically improve with continued use as tolerated. Glycemic changes accrue with adherence and background therapies. Weight may change gradually for some, but responses differ. Consistent daily timing, site rotation, and adherence to the prescribed dose can support steady outcomes. Regular follow-up with a healthcare professional and recommended lab monitoring help assess response and safety.

Compare With Alternatives

Several GLP-1 or related agents are approved for type 2 diabetes. Semaglutide is a once-weekly option; see Semaglutide Pens. Dual GIP/GLP-1 agonists are available; see Mounjaro. Selection depends on clinical history, dosing preference, and tolerability. Discuss alternatives with a prescriber to align therapy with goals and comorbidities.

Pricing and Access

Canadian pricing with US delivery from Canada helps many patients manage therapy costs. Review the Victoza Prefilled Pen price on this page to understand current options and supply terms. You can also Buy Liraglutide pen online through our platform once a valid prescription is verified. Checkout is encrypted, and orders are processed by licensed pharmacies.

See periodic offers on our Promotions page when available. For broader condition information, visit Type 2 Diabetes and explore related classes under Non Insulin Injectables.

Availability and Substitutions

Supply can vary by pharmacy and season. If an item is unavailable, a prescriber may recommend an alternative in the same class or another glucose-lowering class based on individual needs. Equivalent substitutions must be authorized by the prescriber. Stock status can change without notice; check product listings for current availability.

Patient Suitability and Cost-Saving Tips

Good candidates include adults with type 2 diabetes who need additional glycemic control after diet and exercise, with or without metformin. It may not suit individuals with prior pancreatitis, severe gastrointestinal disease, or the thyroid conditions listed above. Those using insulin or sulfonylureas require careful monitoring for low blood sugar.

To reduce costs, consider multi-month supplies if prescribed, align refill dates to combine parcels, and enroll in reminders so you do not run out. Manufacturer coupons may vary by market. For comparisons, some patients look at the Generic liraglutide pen price even though no true generic is approved in many regions. Review insurance coverage separately, as benefits differ by plan.

Questions to Ask Your Clinician

• Is a GLP-1 right for my current A1C and goals?
• How should I adjust other diabetes medicines when starting?
• What signs of pancreatitis or gallbladder issues should I watch for?
• Which injection sites are best for me and how should I rotate them?
• What labs and follow-up schedule do you recommend?
• If I miss several days, how should I re-titrate per the label?

Authoritative Sources

Novo Nordisk Victoza Prescribing InformationFDA DailyMed: Victoza (liraglutide)Health Canada Drug Product Database: Victoza

Ready to proceed? Order with US delivery from Canada and prompt, express, cold-chain shipping. Always follow the official label and your prescriber’s guidance.